<--- Back to Details
First PageDocument Content
Clinical pharmacology / Food and Drug Administration / Pharmacology / Therapeutics / United States Public Health Service / Investigational Device Exemption / Sexual Offences (Amendment) Act / National Information Infrastructure Protection Act / Pharmaceutical sciences / Research / Clinical research
Date: 2012-04-27 07:33:19
Clinical pharmacology
Food and Drug Administration
Pharmacology
Therapeutics
United States Public Health Service
Investigational Device Exemption
Sexual Offences (Amendment) Act
National Information Infrastructure Protection Act
Pharmaceutical sciences
Research
Clinical research

§ 360bbb–1 TITLE 21—FOOD AND DRUGS

Add to Reading List

Source URL: www.gpo.gov

Download Document from Source Website

File Size: 122,41 KB

Share Document on Facebook

Similar Documents

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

DocID: 1voig - View Document

Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

DocID: 1vapl - View Document

  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

DocID: 1v3IN - View Document

Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

DocID: 1v3kf - View Document

Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

DocID: 1v0Hj - View Document